Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, ...

The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young ...

Vaccines protect us from illnesses all through life, but as we get older the shots we need also change. Read all about them ...

A study conducted at the University of São Paulo (USP) in Brazil reveals that tissues such as the tonsils and adenoids can ...

Vaccinating expectant mothers against RSV reduces hospital admissions in young infants by at least 80 per cent, according to ...

ENFLONSIA is the first and only RSV preventive option in the European Union for administration to infants without the need for weight-based dosingRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: ...

MUNICH, April 18, 2026 /CNW/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the ...

Merck , known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved ENFLONSIAtm (clesrovimab) for the prevention of respiratory syncytial virus ...

An outbreak of the respiratory syncytial virus (RSV) at the East Wing of Rainycrest Long Term Care Home has been declared over, and all resident and visitor restrictions at the home have been lifted, ...

Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds(Saturday, 18 April 2026, Munich, Germany) The largest ...